TDZs and Cardiovascular Outcomes

Mouse over the video, or right click, to activate the controls. This video is 1:38 minutes. You will need the Free QuickTime Player to view it. Additional help for Mac users.



Text Summary
Avandia and Actos have been individually accused of being associated with increased cardiovascular disease. This study involves 12,491 patients 66 years old or older who were taking these drugs and compared them to patients taking one or more hypoglycemic agents.

The study covered a medium of 3.8 years included data from Ontario.

12,491 were admitted to the hospital for congestive heart failure.
12,578 had a heart attack
30,265 died

This is about 4 times the cardiovascular problems of those taking other combination oral hypoglycemic agents.

We virtually have gone in my office for 18 years with only a rare case of these problems. I attribute this success to the l-argi9 plus and the weaker but successful other l-arginine products used previously.